Trials / Completed
CompletedNCT03880747
Dumping Syndrome and Quality of Life After Vagus Nerve-preserving Distal Gastrectomy
Incidence of Dumping Syndrome After Laparoscopic Vagus Nerve-preserving Distal Gastrectomy for Early Gastric Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There is no consensus on what type of function-preserving gastrectomy can provide the best patient quality of life (QOL). This study aims to evaluate the incidence of dumping syndrome after vagus nerve-preserving distal gastrectomy (VPNDG).
Detailed description
The study is designed as a prospective observational phase II study with a follow-up period of 12 months. Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach who are planned to undergo laparoscopic VPNDG with Roux-en Y gastrojejunostomy will be enrolled. Primary endpoint is incidence of dumping syndrome defined by Sigstad score 7 after a 3-month interval. Other outcomes include operative data, early complication, and patient QOL using the European Organization for Research and Treatment of Cancer C-30 and STO22 modules.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Vagus nerve-preserving distal gastrectomy | Laparoscopic distal gastrectomy with the preservation of the celiac and hepatic branch of the vagus nerve. |
Timeline
- Start date
- 2017-08-09
- Primary completion
- 2019-08-19
- Completion
- 2020-08-20
- First posted
- 2019-03-19
- Last updated
- 2021-03-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03880747. Inclusion in this directory is not an endorsement.